T.P. Sloan

973 total citations · 1 hit paper
12 papers, 780 citations indexed

About

T.P. Sloan is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, T.P. Sloan has authored 12 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in T.P. Sloan's work include Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (2 papers) and Receptor Mechanisms and Signaling (2 papers). T.P. Sloan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (2 papers) and Receptor Mechanisms and Signaling (2 papers). T.P. Sloan collaborates with scholars based in United Kingdom, Nigeria and Ghana. T.P. Sloan's co-authors include Jeffrey R. Idle, A. Mahgoub, Richard L. Smith, David A. Evans, Enitan A. Bababunmi, Richard Lancaster, N. M. Woolhouse, Robert L. Smith, RL Smith and Philip A. Wood and has published in prestigious journals such as British Journal of Pharmacology, Cancer Letters and Clinical Pharmacology & Therapeutics.

In The Last Decade

T.P. Sloan

12 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1980 448 citations David A. Evans, A. Mahgoub et al. Journal of Medical Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T.P. Sloan United Kingdom	8	483	223	170	100	90	12	780
E Jacqz United States	12	512 1.1×	248 1.1×	154 0.9×	139 1.4×	20 0.2×	17	919
MJ Brodie United Kingdom	16	387 0.8×	225 1.0×	148 0.9×	390 3.9×	21 0.2×	33	920
Rahul Shah United States	14	309 0.6×	169 0.8×	156 0.9×	69 0.7×	16 0.2×	36	785
Ruby C. Chou Switzerland	17	395 0.8×	224 1.0×	230 1.4×	80 0.8×	15 0.2×	28	846
C Zekorn Germany	8	306 0.6×	168 0.8×	94 0.6×	65 0.7×	18 0.2×	10	510
U. Jeppesen Denmark	8	327 0.7×	149 0.7×	94 0.6×	70 0.7×	24 0.3×	10	824
H.‐U. Schulz Germany	15	239 0.5×	154 0.7×	141 0.8×	166 1.7×	21 0.2×	49	912
N S Oates United Kingdom	9	330 0.7×	138 0.6×	116 0.7×	57 0.6×	13 0.1×	11	507
C von Bahr Sweden	11	244 0.5×	122 0.5×	165 1.0×	100 1.0×	6 0.1×	22	555
K Hrubý Austria	11	221 0.5×	61 0.3×	109 0.6×	32 0.3×	40 0.4×	71	573

Countries citing papers authored by T.P. Sloan

Since Specialization

Citations

This map shows the geographic impact of T.P. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.P. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.P. Sloan more than expected).

Fields of papers citing papers by T.P. Sloan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.P. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.P. Sloan. The network helps show where T.P. Sloan may publish in the future.

Co-authorship network of co-authors of T.P. Sloan

This figure shows the co-authorship network connecting the top 25 collaborators of T.P. Sloan. A scholar is included among the top collaborators of T.P. Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.P. Sloan. T.P. Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Oates, N S, et al.. (1984). Genetic heterogeneity of histamine H₂‐receptors in the mouse vas deferens. British Journal of Pharmacology. 83(3). 723–731. 3 indexed citations

2.

Idle, Jeffrey R., et al.. (1981). Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Letters. 11(4). 331–338. 64 indexed citations

3.

Bababunmi, Enitan A., et al.. (1980). A study of the debrisoquine hydroxylation polymorphism in a Nigerian population. Xenobiotica. 10(11). 811–818. 55 indexed citations

4.

Sloan, T.P., et al.. (1980). A family andpopulation study ofthegenetic polymorphism ofdebrisoquine oxidation ina white British population. 2 indexed citations

5.

Mucklow, JC, et al.. (1980). The influence of changes in dietary fat on the clearance of antipyrine and 4‐hydroxylation of debrisoquine.. British Journal of Clinical Pharmacology. 9(3). 283P–283P. 12 indexed citations

6.

Evans, David A., A. Mahgoub, T.P. Sloan, Jeffrey R. Idle, & Richard L. Smith. (1980). A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.. Journal of Medical Genetics. 17(2). 102–105. 448 indexed citations breakdown →

7.

Woolhouse, N. M., et al.. (1979). Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians. Clinical Pharmacology & Therapeutics. 26(5). 584–591. 73 indexed citations

8.

Idle, Jeffrey R., et al.. (1979). Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings].. PubMed. 66(3). 430P–431P. 18 indexed citations

9.

Idle, Jeffrey R., et al.. (1979). Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings].. PubMed. 66(3). 431P–431P. 2 indexed citations

10.

Sloan, T.P., et al.. (1979). Genetic evidence for the involvement of different oxidative mechanisms in drug oxidation. Journal of Pharmacy and Pharmacology. 31(1). 350–352. 10 indexed citations

11.

Sloan, T.P., A. Mahgoub, Richard Lancaster, Jeffrey R. Idle, & Richard L. Smith. (1978). Polymorphism of carbon oxidation of drugs and clinical implications.. BMJ. 2(6138). 655–657. 92 indexed citations

12.

Breckenridge, A, et al.. (1978). 242. Plasma ethinyloestradiol concentration in rabbits and women. Journal of Steroid Biochemistry. 9(9). 863–863. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact